An international research consortium focused on improving care for solid organ transplant recipients affected by antimicrobial resistance.
Participating Centers
Countries Involved
Active Studies
Project Launch
CARVA-SOT is a European-led international research network dedicated to tackling multidrug-resistant infections in solid organ transplant recipients. The consortium brings together clinical and research institutions from Spain, Italy, Brazil, and other countries, fostering collaboration to improve patient outcomes and advance scientific knowledge in transplant medicine.
Transplant patients are especially vulnerable to resistant infections. CARVA-SOT was created to generate shared knowledge, harmonize clinical data, and support evidence-based decision-making at an international level.
CARBA-SOT connects clinicians, researchers, and institutions across countries to enable coordinated, high-impact research on antimicrobial resistance in transplant medicine.
Clinicians, microbiologists, epidemiologists, and transplant specialists working together.
Participating centers across Europe and Latin America.
Promoters and national coordinators ensure aligned research efforts.
Harmonized clinical data to support robust multicenter studies.
A multicenter retrospective study focused on evaluating the clinical impact, risk factors, and outcomes of multidrug-resistant infections in kidney transplant recipients across participating centers.
A prospective study focused on monitoring and preventing antimicrobial resistance in liver transplant patients across participating centers.
CARBA-SOT welcomes research institutions, healthcare professionals, and international partners interested in advancing knowledge and improving care in transplant-related infections.
